Source:http://linkedlifedata.com/resource/pubmed/id/20088715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-1-21
|
pubmed:abstractText |
Despite the clinical benefits of highly active antiretroviral therapy (HAART), the prospect of life-long antiretroviral treatment poses significant problems, which has spurred interest in developing new drugs and strategies to treat HIV infection and eliminate persistent viral reservoirs. RNAi has emerged as a therapeutic possibility for HIV.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1744-7682
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-13
|
pubmed:dateRevised |
2011-8-1
|
pubmed:meshHeading |
pubmed-meshheading:20088715-Animals,
pubmed-meshheading:20088715-Drug Design,
pubmed-meshheading:20088715-Genes, Viral,
pubmed-meshheading:20088715-Genetic Vectors,
pubmed-meshheading:20088715-HIV Infections,
pubmed-meshheading:20088715-HIV-1,
pubmed-meshheading:20088715-Humans,
pubmed-meshheading:20088715-RNA, Small Interfering,
pubmed-meshheading:20088715-RNA Interference
|
pubmed:year |
2010
|
pubmed:articleTitle |
RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?
|
pubmed:affiliation |
Texas Tech University Health Sciences Center, Center of Excellence for Infectious Diseases, Paul L. Foster School of Medicine, Department of Biomedical Sciences, El Paso, TX 79905, USA.
|
pubmed:publicationType |
Journal Article,
Review
|